Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33069
Title: Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply.
Austin Authors: Mårtensson, Johan;Bellomo, Rinaldo 
Affiliation: Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care, Karolinska Institutet, Stockholm, Sweden.
Intensive Care
Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, 171 76, Stockholm, Sweden. johan.martensson@regionstockholm.se.
Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.;Department of Critical Care, Melbourne University, Melbourne, VIC, Australia.;Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.
Issue Date: 8-Jun-2023
Date: 2023
Publication information: Critical Care (London, England) 2023-06-08; 27(1)
URI: https://ahro.austin.org.au/austinjspui/handle/1/33069
DOI: 10.1186/s13054-023-04513-7
ORCID: 
Journal: Critical Care (London, England)
Start page: 225
PubMed URL: 37291591
ISSN: 1466-609X
Type: Journal Article
Subjects: Sodium-Glucose Transporter 2 Inhibitors/pharmacology
Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
Sepsis/drug therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

20
checked on Dec 10, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.